Prostate Health

FDA approves new drug for men at high risk of prostate cancer spread

Charlie Schmidt

Editor, Harvard Medical School Annual Report on Prostate Diseases

Men whose PSA levels continue rising even after surgery or radiation therapy may have a new treatment option with the approval of the drug apalutamide.

FDA approves new drug for men at high risk of prostate cancer spread

Charlie Schmidt

Editor, Harvard Medical School Annual Report on Prostate Diseases

A newly approved drug called apalutamide is giving hope to thousands of men confronting a tenacious problem after being treated for prostate cancer. Prostate-specific antigen (PSA) levels should plummet to zero after surgery, and to near zero after radiation therapy, but in some men, they continue rising even when there’s no other evidence of cancer […]

Newer drugs are improving survival for men with metastatic prostate cancer

Charlie Schmidt

Editor, Harvard Medical School Annual Report on Prostate Diseases

Men with prostate cancer that has spread outside the gland now have several newer drug options available for treatment, and research has found that taking any of them is likely to improve survival duration.

We heard you — incontinence affects men too. Here’s what you need to know

Matthew Solan

Executive Editor, Harvard Men's Health Watch

Urinary incontinence is more common in women, but men experience it too, particularly as they get older. Whether it’s urge incontinence or stress incontinence, there are strategies and treatments that can help.

New study downplays potential risk of dementia and Alzheimer’s disease among elderly men treated with hormonal therapy for prostate cancer

Charlie Schmidt

Editor, Harvard Medical School Annual Report on Prostate Diseases

The male hormone testosterone contributes to normal brain function, and some research links memory loss in older men to testosterone declines that occur naturally with aging. However, testosterone is also like jet fuel for prostate tumors, causing them to grow faster, so during cancer treatment doctors will often give hormonal therapies that suppress its activities […]

Study investigates treatment regret among prostate cancer survivors

Charlie Schmidt

Editor, Harvard Medical School Annual Report on Prostate Diseases

Surveys of over 900 men who were diagnosed with prostate cancer in the 1990s found that approximately 15% had some regret over their treatment choices. Study authors encourage doctors and patients to have frank and thorough discussions about about the risks and benefits of various forms of treatment for prostate cancer.

Study investigates treatment regret among prostate cancer survivors

Charlie Schmidt

Editor, Harvard Medical School Annual Report on Prostate Diseases

Charles Schmidt As they get older, do men with prostate cancer come to regret the treatment decisions they made? A new study of men diagnosed during the mid-1990s indicates that some of them will. Richard Hoffman, a professor of internal medicine and epidemiology at the University of Iowa Carver College of Medicine in Iowa City, […]

New study supports lifesaving benefits from PSA screening

Charlie Schmidt

Editor, Harvard Medical School Annual Report on Prostate Diseases

Charles Schmidt Does screening for prostate cancer with the prostate-specific antigen (PSA) test save lives? A new study suggests that it does, but at the risk of exposing men with slow-growing tumors that may not be life-threatening to treatments they may not really need. Published in Annals of Internal Medicine, the study reconciles conflicting results […]

Time to rethink the debate on PSA testing

The debate about PSA screening for prostate cancer has been going on for decades, and research has been similarly divided. For most men, the best advice is to talk with your doctor so the benefits and risks of the test are clear.

Strong study shows no link between vasectomy and prostate cancer

Charlie Schmidt

Editor, Harvard Medical School Annual Report on Prostate Diseases

In contrast to earlier research, a review of dozens of studies involving millions of men who had vasectomies found no proof that having a vasectomy increases a man’s risk of prostate cancer.